Iratumumab
Term · Oncology and biomedicine · MLC-T-ONC-014567
A fully human monoclonal antibody with potential antineoplastic activity. MDX-060 is a fully humanized antibody that targets CD30, a member of the tumor necrosis factor receptor superfamily found on activated lymphocytes. CD30 is over-expressed in various lymphoproliferative disorders, Hodgkin disease and other lymphomas, and other cancers.
| Identifier | MLC-T-ONC-014567 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | MDX-060; monoclonal antibody MDX-060 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014567",
"term": "Iratumumab",
"field": "Oncology and biomedicine",
"definition": "A fully human monoclonal antibody with potential antineoplastic activity. MDX-060 is a fully humanized antibody that targets CD30, a member of the tumor necrosis factor receptor superfamily found on activated lymphocytes. CD30 is over-expressed in various lymphoproliferative disorders, Hodgkin disease and other lymphomas, and other cancers.",
"synonyms": [
"MDX-060",
"monoclonal antibody MDX-060"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/iratumumab/"
}
Record 9,564 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.